Get started
Author

Xenia Villalobos

Observed names: Villalobos Alberu Xenia, X. Villalobos, X. Villalobos Alberú, Xenia Sofia Villalobos Alberú, Xenia Villalobos Alberu, Xenia Villalobos Alberú
ORCID: 0000-0003-1232-980X
Observed ORCID: 0000-0003-1232-980X
OpenAlex ID: A5019628788
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
2022 · David Tamborero, Rodrigo Dienstmann, et al. · Nature Cancer · 127
PDF
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
2020 · David Tamborero, Rodrigo Dienstmann, et al. · Nature Medicine · 88
PDF
Polypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo
2013 · Laura Rodríguez, Xenia Villalobos, et al. · Biochemical Pharmacology · 40
Overexpression of S100A4 in human cancer cell lines resistant to methotrexate
2010 · Nuria Mencía, Elisabet Selga, et al. · BMC Cancer · 35
PDF
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group
2024 · Alexander W. Wyatt, Saskia Litiere, et al. · Clinical Cancer Research · 34
PDF
Stability and Immunogenicity Properties of the Gene-Silencing Polypurine Reverse Hoogsteen Hairpins
2013 · Xenia Villalobos, Laura Rodríguez, et al. · Molecular Pharmaceutics · 32
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer
2024 · M. Polack, M.A. Smit, et al. · ESMO Open · 29
PDF
Polypurine Reverse Hoogsteen Hairpins as a Gene Silencing Tool for Cancer
2017 · Carlos J. Ciudad, Laura Rodríguez, et al. · Current Medicinal Chemistry · 24
Effect of Polypurine Reverse Hoogsteen Hairpins on Relevant Cancer Target Genes in Different Human Cell Lines
2015 · Xenia Villalobos, Laura Rodríguez, et al. · Nucleic Acid Therapeutics · 24
Improved Design of PPRHs for Gene Silencing
2015 · Laura Rodríguez, Xenia Villalobos, et al. · Molecular Pharmaceutics · 23
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis
2025 · S. Martín-Lluesma, U. Dafni, et al. · Annals of Oncology · 13
Validation of miRNA-mRNA interactions by electrophoretic mobility shift assays
2013 · Anna Solé, Núria Mencia, et al. · BMC Research Notes · 13
PDF
Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project
2023 · Paola Mosconi, Cinzia Colombo, et al. · BMC Cancer · 9
PDF
Repair of Single-Point Mutations by Polypurine Reverse Hoogsteen Hairpins
2014 · Anna Solé, Xenia Villalobos, et al. · Human Gene Therapy Methods · 9
Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
2022 · David Tamborero, Rodrigo Dienstmann, et al. · Nature Cancer · 6
PDF
Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers
2024 · J. Palomero, V. Galvao, et al. · Immuno-Oncology Technology · 5
The UpSMART Accelerator: driving digital innovation to change the conduct of early phase cancer medicine trials
2022 · Butt Fouziah, Stephenson Laura, et al. · Digital Medicine · 1
2904P Co-creation and iterative needs assessment with patients and healthcare providers in an International phase II TILs therapy trial (PRAGMATIL)
2025 · P. Cacilhas, R. Malagrida, et al. · Annals of Oncology
PDF
Abstract P2-12-27: A phase Ib study of the safety, tolerability, biological effect, and efficacy of allogenic natural killer cells in combination with trastuzumab and pertuzumab in patients with refractory HER2-positive metastatic breast cancer
2025 · Santiago Escrivá-de-Romaní, Vladimir Galvao, et al. · Clinical Cancer Research
Abstract CT093: Cancer Core Europe - Basket of Baskets - first results from module 1: Atezolizumab in genomically selected populations
2025 · Irene Brana, Christophe Massard, et al. · Cancer Research
1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT)
2023 · V. Galvao, J. Palomero, et al. · Annals of Oncology
PDF
438P Real-world data of relapse after adjuvant treatment (Tx) in high-risk melanoma
2020 · C. Ortiz Velez, G. Villacampa Javierre, et al. · Annals of Oncology
Polypurine Reverse Hoogsteen hairpins: stability, lack of immunogenicity and gene silencing in cancer therapy
2015 · Xenia Sofia Villalobos Alberú · TDX (Tesis Doctorals en Xarxa)
Works count: 23
Citation count: 509
H-index: 12
I10-index: 12
Year
Topic
Type